Canada Markets open in 2 hrs 29 mins
  • S&P/TSX

    21,274.57
    -262.88 (-1.22%)
     
  • S&P 500

    4,577.11
    -85.74 (-1.84%)
     
  • DOW

    35,368.47
    -543.34 (-1.51%)
     
  • CAD/USD

    0.8016
    +0.0020 (+0.2517%)
     
  • CRUDE OIL

    86.63
    +1.20 (+1.40%)
     
  • BTC-CAD

    52,411.99
    -54.96 (-0.10%)
     
  • CMC Crypto 200

    997.26
    -12.13 (-1.20%)
     
  • GOLD FUTURES

    1,818.10
    +5.70 (+0.31%)
     
  • RUSSELL 2000

    2,096.23
    -66.23 (-3.06%)
     
  • 10-Yr Bond

    1.8650
    0.0000 (0.00%)
     
  • NASDAQ futures

    15,272.25
    +66.25 (+0.44%)
     
  • VOLATILITY

    22.30
    +3.11 (+16.21%)
     
  • FTSE

    7,585.02
    +21.47 (+0.28%)
     
  • NIKKEI 225

    27,467.23
    -790.02 (-2.80%)
     
  • CAD/EUR

    0.7066
    +0.0012 (+0.17%)
     

US panel weighs whether to OK Merck COVID-19 pill

U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients. The FDA asked its outside experts Tuesday whether the agency should authorize the pill. (Nov. 30)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting